(R)-(-)-Ibuprofen structure
|
Common Name | (R)-(-)-Ibuprofen | ||
|---|---|---|---|---|
| CAS Number | 51146-57-7 | Molecular Weight | 206.281 | |
| Density | 1.0±0.1 g/cm3 | Boiling Point | 319.6±11.0 °C at 760 mmHg | |
| Molecular Formula | C13H18O2 | Melting Point | 41-42ºC | |
| MSDS | N/A | Flash Point | 216.7±14.4 °C | |
Use of (R)-(-)-Ibuprofen(R)-(-)-Ibuprofen is the R enantiomer of Ibuprofen, inactive on COX, inhibits NF-κB activation; (R)-(-)-Ibuprofen exhibits anti-inflammatory and antinociceptive effects. |
| Name | levibuprofen |
|---|---|
| Synonym | More Synonyms |
| Description | (R)-(-)-Ibuprofen is the R enantiomer of Ibuprofen, inactive on COX, inhibits NF-κB activation; (R)-(-)-Ibuprofen exhibits anti-inflammatory and antinociceptive effects. |
|---|---|
| Related Catalog | |
| Target |
NF-κB |
| In Vitro | (R)-(-)-Ibuprofen is the R enantiomer of Ibuprofen, with no inhibitory effect on COX, but is involved in pathways of lipid metabolism and is incorporated into triglycerides along with endogenous fatty acids[1]. (R)-(-)-Ibuprofen (1 μM) significantly reduces NF-κB activation and completely prevents NF-κB induction at 10 μM. (R)-(-)-Ibuprofen inhibits NF-κB luciferase activity with an IC50 of 121.8 μM, weaker than that of S(+)-ibuprofen (IC50, 61.7 μM). Furthermore, (R)-(-)-Ibuprofen (10 mM) has no effect on HSF[2]. |
| References |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 319.6±11.0 °C at 760 mmHg |
| Melting Point | 41-42ºC |
| Molecular Formula | C13H18O2 |
| Molecular Weight | 206.281 |
| Flash Point | 216.7±14.4 °C |
| Exact Mass | 206.130676 |
| PSA | 37.30000 |
| LogP | 3.72 |
| Vapour Pressure | 0.0±0.7 mmHg at 25°C |
| Index of Refraction | 1.519 |
| InChIKey | HEFNNWSXXWATRW-SNVBAGLBSA-N |
| SMILES | CC(C)Cc1ccc(C(C)C(=O)O)cc1 |
| HS Code | 2916399090 |
|---|
| Precursor 9 | |
|---|---|
| DownStream 1 | |
| HS Code | 2916399090 |
|---|---|
| Summary | 2916399090 other aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |
| Inoven |
| Lebrufen |
| (RS)-ibuprofen |
| Ibumetin |
| Femadon |
| 2-(4-Isobutylphenyl)propionic acid |
| QVY1&R D1Y1&1 |
| l-Ibuprofen |
| Para-Isobutylhydratropic Acid |
| Ibuprofen |
| (2R)-2-(4-Isobutylphenyl)propanoic acid |
| (R)-2-(4-Isobutylphenyl)propanoic acid |
| Benzeneacetic acid, α-methyl-4-(2-methylpropyl)- |
| (±)-ibuprofen |
| Novogent N |
| Ibutid |
| fenbid |
| 2-(4-Isobutylphenyl)propanoic acid |
| MOTRIN |
| Dolgirid |
| (R)-Ibuprofen |
| Amibufen |
| (-)-ibuprofen |
| Nurofen |
| (R)-(-)-Ibuprofen |
| Racemic ibuprofen |
| (2R)-2-[4-(2-methylpropyl)phenyl]propanoic acid |
| Advil |
| Brufen |
| Dolo-Dolgit |
| Seclodin |
| UNII:WK2XYI10QM |
| Benzeneacetic acid, α-methyl-4-(2-methylpropyl)-, (αR)- |
| IbU |
| Panafen |